Chemistry of Behaviour Flashcards

1
Q

Neurochemistry

A

chemical processes in the neurosystem (endogenous system, present in the system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neuropharmacology

A

effects of drugs on neurosystem (exogenous processes, compound)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ionotropic receptor

A
  • Ligand gated
  • Opens ion channel
  • Fast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Metabotropic receptor

A
  • G protein-coupled
  • Second messengers: g protein activation
  • Slow, longer lasting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Receptors

A

protein molecules embedded in the postsynaptic membrane that recognize a specific transmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Receptor agonist

A

drugs that block the transmitter and open gate -> normal effects of the transmitter on that receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Competitive antagonist

A

neurotransmitter block the receptor and the agonist to act

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Non-competitive agonist/antagonist

A

they bind on different places

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholinergic pathways

A

Cholinergic pathways -> play a role in muscle control and memory

  • Nicotine receptors -> ionotropic (important in muscular system)
  • Muscarinic receptors -> metabotropic (role in memory)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dopaminergic pathways

A
  • Mesostriatal pathway
    ○ From substantia nigra (black matter) to the striatum
    ○ Role in motor control
    ○ Main area affected in Parkinson’s disease
  • Mesolimbocortical pathway
    ○ From VTA to limbic system
    Reward/reinforcement (change in dopamine level)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Noradrenergic pathway

A
  • Norepinephrine = noradrenaline, from locus coeruleus to broadly area in the brain
  • Active role in body and the brain (sympathetic nervous system)
    ○ Connect neural system to the body (active response)
    ○ Activating mental functions in the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Serotonergic (5-HT) pathways

A
  • from raphe nuclei (in the midbrain)
  • they project to mostly all the part of the brain -> control of mood, anxiety and sleep
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 type of drugs

A

1) Medicine used in treatment of a disease
2) Drugs of abuse, used recreationally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effective dose 50 (ED50)

A

dose at which 50 % of the effect is shown or test population show effects (y or n)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lethal dose 50 (LD50)

A

dose at which 50 % of the population dies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Therapeutic index

A

Window between ED50 and LD50.
The therapeutical index refers to the separation between useful doses of the drug and dangerous doses.

17
Q

Metabolic tolerance

A

organ system become more effective in eliminating the drugs from the bloodstream

18
Q

Functional tolerance

A

target tissue may show altered sensitivity to the drug (regulation of the number of receptors)

19
Q

Cross-tolerance.

A

Tolerance to a drug often generalised to other drugs belonging to the same chemical class

20
Q

sensitization

A

Some drugs responses can become stronger with repeated treatments, rather than weaker

21
Q

Regulation of the number of receptors for drugs

A
  • When the drug is an agonist (increase activation) -> down-regulation (few receptor are needed for the same effect)
  • When the drug is an antagonist -> up regulation of the number of receptors in the membrane (member of receptors became smaller)
22
Q

Antipsychotics

A

Antipsychotics -> affects post-synaptic neurons

Typical:
- Dopamine D2 antagonist
- Reduce positive symptom of schizophrenia

Atypical:
- S-HT antagonist
- Reduce negative symptoms of schizophrenia

23
Q

Antidepressants

A

Antidepressants -> use to cure depression

  • MonoAmineOxidase (MAO) inhibitor: inhibits an enzyme in the presynaptic that inhibits the degradation of this neurotransmitter -> more neurotransmitter remaining present in the pre-synaptic cells and more available to be released.
  • Tricyclic antidepressants: reuptake inhibitor -> not very specific (inhibit a lot) -> many inhibit path that don’t want to inhibit
  • SSRI: selective serotonin reuptake inhibitor -> more specific and beneficial (increase serotonin -> benefit patient)
24
Q

Anxiolytics

A

Anxiolytics -> treat anxiety disorder (family of sedatives)

  • Benzodiazepines: Gaba agonist that activate the same receptor as Gaba (inhibitor neuron) and reduce nervous system activity
25
Moral model
drugs users can be blame for the abuse (lack of control), religion need to overcame abuse
26
Disease model
drug abuse as a medical condition, difficult to find physical origin for drugs abuse (genetic predisposition?)
27
Physical dependence model
people continue taking drugs for avoiding the symptoms of withdraw. This model don't say anything about why people start initially
28
Positive reward model
drugs make you feeling good -> feeling of reward